Related Experiment Video
Updated: Dec 23, 2025
05:50
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
1.2K
PyRod Enables Rational Homology Model-based Virtual Screening Against MCHR1
David Schaller1, Gerhard Wolber1
1Pharmaceutical and Medicinal Chemistry, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195, Berlin, Germany.
Molecular Informatics
|April 25, 2020
Summary
Developing accurate 3D pharmacophores for melanin-concentrating hormone receptor 1 (MCHR1) is crucial for anti-obesity drug discovery. This study introduces a novel method using molecular dynamics simulations and PyRod software to overcome challenges posed by receptor flexibility.
Area of Science:
- Pharmacology
- Computational Chemistry
- Drug Discovery
Background:
- Melanin-concentrating hormone receptor 1 (MCHR1) is a key target for anti-obesity drug development.
- Lack of experimentally resolved MCHR1 structures hinders rational drug design.
Purpose of the Study:
- To develop accurate, homology model-based 3D pharmacophores for MCHR1.
- To address limitations of traditional docking approaches due to binding pocket flexibility.
Main Methods:
- Utilized molecular dynamics simulations with novel open-source software PyRod.
- Derived 3D pharmacophores from simulation data.
- Performed retrospective evaluation of pharmacophore predictive power.
Main Results:
- Generated highly predictive 3D pharmacophores for MCHR1.
- Achieved up to 35% retrieval of active molecules and an early enrichment (EF1) of 27.6.
- PyRod pharmacophores showed higher sensitivity and provided structural insights compared to ligand-based methods.
Conclusions:
- Novel PyRod-based pharmacophores offer a promising strategy for MCHR1 drug design.
- This approach overcomes challenges associated with receptor flexibility.
- The derived pharmacophores facilitate rational lead optimization for anti-obesity therapeutics.
